INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2018

Higher circulating vitamin D levels were linked to better overall survival in breast cancer patients in a dose-response meta-analysis.

A meta-analysis of six studies including 5,984 breast cancer patients explored the dose-response relationship between circulating 25-hydroxyvitamin D levels and overall survival. Comparing the highest with the lowest vitamin D category yielded a pooled hazard ratio of 0.67 (95% CI: 0.56-0.79, P < .001). A linear dose-response analysis found a pooled hazard ratio for overall survival of 0.994 per 1 nmol/L (P for linear trend < .001), with increments of 10, 20, or 25 nmol/L at or above 23.3 nmol/L associated with 6%, 12%, and 14% lower risks of overall mortality. Authors note that better designed prospective cohort studies and clinical trials are needed to confirm these findings.

Shows an association, not proof of cause and effect.

Study type
Dose-response meta-analysis of cohort studies
Who was studied
5,984 breast cancer patients across 6 studies
What was measured
Overall survival and overall mortality

THE PAPER

Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.

Hu K, Callen DF, Li J, Zheng H. Integr Cancer Ther, 2018.

PubMed 28589744 ↗DOI 10.1177/1534735417712007 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.